The evolution and refinement of traditional risk factors for cardiovascular disease

Area of Science:

• Cardiology
• Epidemiology
• Preventive Medicine

Background:

• Traditional cardiovascular disease risk factors like hypertension and hypercholesterolemia are well-established but limited in number.
• Current risk assessment models often underestimate cardiovascular disease risk, particularly before and during pharmacotherapy.
• Efforts to identify new risk factors have faced challenges due to the high burden of proof for causality.

Purpose of the Study:

• To explore improved metrics for known cardiovascular disease risk factors.
• To address the detection gap in cardiovascular disease risk assessment.
• To enhance the accuracy of cardiovascular disease risk evaluation.

Main Methods:

• Review of evolving measurement techniques for traditional cardiovascular risk factors.
• Investigation of novel biomarkers and advanced metrics for established conditions.
• Focus on enhanced assessment of ambulatory blood pressure and central hemodynamics.
• Inclusion of low-density lipoprotein particle concentration and genetic testing.
• Exploration of the concept of "vascular age" as a risk indicator.

Main Results:

• Traditional risk factor assessment is evolving with more precise metrics.
• Advanced measures like ambulatory blood pressure and LDL particle concentration offer improved risk evaluation.
• Newer approaches, including genetic testing and vascular age, show promise in refining cardiovascular risk detection.
• These enhanced metrics may help bridge the gap in identifying individuals at risk.

Conclusions:

• Improved metrics for traditional cardiovascular disease risk factors are crucial for accurate risk assessment.
• Advanced assessment tools offer a promising solution to the underestimation of cardiovascular disease risk.
• The evolution of risk factor measurement, including vascular age, may significantly improve cardiovascular disease detection and management.